Efficacy Study of CHG Regimen vs Decitabine to Treat Higher-risk MDS

Clinical trial NCT01417767 · UNKNOWN

Trial details

NCT number: NCT01417767
Sponsor: Xiao Li
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2011-09-01
Primary completion: 2013-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.